Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
Indexed incrossrefdoajpubmed
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by chronic ovulation dysfunction and overabundance of androgens; it affects 6-20% of women of reproductive age. PCOS involves various pathophysiological factors, and affected women usually have significant insulin resistance (IR), which is a major cause of PCOS. IR and compensatory hyperinsulinaemia have differing pathogeneses in various tissues, and IR varies among different PCOS phenotypes. Genetic and epigenetic changes, hyperandrogenaemia, and obesity aggravate IR. Insulin sensitization drugs are a new treatment modality for PCOS. We searched PubMed, Google Scholar, Elsevier, and UpToDate databases in this review, and focused on…
Citation impact
335
total citations
- FWCI
- 85.77
- Percentile
- 100%
- References
- 228
Citations per year
Authors
5Topics & keywords
Topics
Keywords
- Polycystic ovary
- Insulin resistance
- Medicine
- Bioinformatics
- Pathogenesis
- Endocrine system
- Internal medicine
- Endocrinology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.